All Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cancer, Nerouology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers' and Babies Health. Clinical trials are an essential component of helathcare. They provide the evidence to evaluate the safety and efficacy of new treantments and diagnositics, and provide alternative treatment options for patients with unmet needs.
Healing and Disease-Modifying Effect of Guselkumab in Crohn’s Disease Patients
A disease modification drug for Temporal Lobe Epilepsy
A disease modification drug for Temporal Lobe Epilepsy
Phase 3 Study of Revumenib in Combination with Intensive Chemotherapy in Newly Diagnosed NPM1-mutated AML
SNDX-6352-0506 - Axatilimab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Axatilimab is a “monoclonal antibody”, which is an antibody manufactured in a laboratory. It is designed to specifically block a protein believed to be involved in lung fibrosis. By blocking this protein, Axatilimab may slow or stop the progression of IPF.
An induction study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease
Assessing the use of Stomal Sponge's to reduce the frequency of neonatal stoma-bag leakage
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Do you have Locally-advanced or Metastatic Non-squamous NSCLC With High PD-L1 Expression?
Do you have Chrohn's disease?
A post-marketing study of UPadacitinib evaluating speed of onset and durability of effectiveness for patients with moderate to severe Crohn’s disease for 3 years in the real-world
A study looking at bowel healing for patients